Sign in
Taking people in United StatesEarly phase 1

Aspirin Dosing in Pregnancy

Key facts

Who runs it
NYU Langone Health
Where
New York, United StatesSee the site
Trial code
Status
Recruiting
Phase
Early phase 1
People taking part
30 people, planned
Started
27 Apr 2026
Expected to end
20 Feb 2028
Type of study
Interventional
Treatments tested
  • Aspirin
Record updated
18 May 2026

Who can take part

Age
18 years to 50 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Pregnant people prior to 17 weeks
  • Prenatal care at NYU Langone Health Obstetrics and Gynecology Associates
  • Age 18-50 years
  • Singleton viable gestation
  • Pregnant patients at high risk of preeclampsia: Patients meeting USPSTF recommendation for aspirin prophylaxis for preeclampsia based on clinical risk factors

Who cannot take part

  • Antithrombotic or antiplatelet therapy
  • Allergy or intolerance to aspirin
  • Undergoing glucose challenge test (GCT) at time of blood draw
  • Anemia (hemoglobin <10 g/dl) or thrombocytopenia (platelet count <100,000), or thrombocytosis (platelet count >600,000)
  • Known hemorrhagic diathesis
  • Planned delivery outside of NYU

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Where in United States

  • NYU Langone HealthNew York, United StatesContact: Christina A. Penfield, MD, MPHTaking people

About the trial

What the trial wants to find out

The purpose of this study is assess platelet phenotypes based on aspirin dosing in pregnant patients at risk for the development preeclampsia who are taking 81mg twice a day aspirin. Blood samples will be collected approximately 4 weeks after initiation of aspirin to evaluate the platelet phenotype during pregnancy in patients.

The group in the trial

  • Twice daily dosing of AspirinTreatment being tested

    Participants will take 81mg Aspirin orally, twice daily (162mg total) for 4 weeks and then return to the dosing regimen as prescribed by the discretion of their treating physician.

    Treatment: Aspirin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Aspirin Dosing and Platelet Phenotype in Pregnancy
Criteria questions
Built from NCT07525635, who can take part
Record updated
18 May 2026